[REVISION HISTORY]
Discovery of skull-based immune structures
Updated 2 times since CLSTR started tracking revisions of this situation.
What changed
2026-08-22 11:06 UTC → 2026-09-04 09:54 UTC ·
added
removed
Researchers from Washington University in St. Louis have identified previously unknown immunological structures located within the bone marrow of the skull. Published in the journal Nature, the study describes these formations as an “immune security station” or lymphoid structures similar to lymph nodes, primarily situated in the posterior regions of the skull, such as the occipital and interparietal bones. The discovery challenges the long-held scientific belief that the brain’s immune system is largely isolated from the rest of the body. The research demonstrates a communication pathway where molecules from the brain can reach the skull bone marrow, which contains specialized immune cells including B cells, follicular helper T cells, and antigen-presenting cells. These areas feature germinal-like centers where B cells activate to produce antibodies. Scientists identified small channels leading from brain tissue through the dura mater directly into the skull, facilitating this connection. In studies involving mice with glioma, an aggressive brain cancer, researchers found that inhibiting these skull-based immune structures led to faster tumor progression and lower survival rates. Lead author and neuroimmunologist Jonathan Kipnis noted that the skull bone marrow acts as a “safety barrier” in the early stages of brain cancer. While the discovery was made in mice, researchers believe there are indications that similar structures exist in humans. Strengthening these immune centers through specific proteins could provide new therapeutic avenues for treating brain cancer avenues. Subsequent research led by Harvard Medical School suggests these structures act as localized immune hubs that serve as rapid first responders. This activity may be linked to chronic pain and neurodegenerative diseases. various neurological conditions. Specifically, elevated levels of the protein translocator protein (TSPO) have been observed near the skull bone marrow in individuals with migraines and visual aura. Scientists believe this activation might represent a neuroimmune response shared across conditions including Alzheimer’s disease, stroke, depression, and autism.
Versions
- 2026-09-04 09:54 UTC Discovery of skull-based immune structures
- 2026-08-22 11:06 UTC Discovery of skull-based immune structures
- 2026-08-21 12:20 UTC Discovery of skull-based immune structures
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.